These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides. Van der Auwera P, Schuyteneer F. J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673 [Abstract] [Full Text] [Related]
29. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer. Feld R, Valdivieso M, Bodey GP, Rodriguez V. J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853 [Abstract] [Full Text] [Related]
33. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin]. Wundt W, Lange KP, Baumgärtner M. Arzneimittelforschung; 1985 Mar; 35(8):1322-5. PubMed ID: 3935123 [Abstract] [Full Text] [Related]
34. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)]. Segura C, Foz A, Fuster C, Tirado M, Roy C. Med Clin (Barc); 1981 Jun 25; 77(2):50-5. PubMed ID: 6798336 [Abstract] [Full Text] [Related]